Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Үндсэн зохиолчид: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2018
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Modeling Fragile X Syndrome in Drosophila
-н: Małgorzata Drozd, зэрэг
Хэвлэсэн: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
-н: Alessandra Tempio, зэрэг
Хэвлэсэн: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
-н: Thomas Maurin, зэрэг
Хэвлэсэн: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
-н: Tovi Anderson, зэрэг
Хэвлэсэн: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
-н: Sara Castagnola, зэрэг
Хэвлэсэн: (2017-11-01)